Monitor whether Menora Mivtachim continues to reduce its position in future filings. The drop below 5% removes the requirement for future 13G filings, so further reductions may go unobserved until the next 13F or a new 5% threshold crossing.
TEVA drugs
TEVA drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 10 $42.40entry
- T+1 · 6d ago +1.98%α +0.66% · $43.24
- T+4 · todayOpen
- T+5 · in 6h Pending
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Menora Mivtachim Holdings Ltd. filed an amended Schedule 13G disclosing a 4.99% passive stake in Teva (58,209,541 ordinary shares) as of November 5, 2026, down from a prior stake that was above 5%. The filing confirms a passive intent and no change of control influence.
Key Financial Metrics
Key Facts
- Menora Mivtachim Holdings Ltd. filed an amended Schedule 13G on November 10, 2026
- Beneficial ownership: 58,209,541 ordinary shares (4.99% of 1,165,296,084 shares outstanding as of November 5, 2026)
- Stake decreased from a prior level above 5% (the filing does not state the prior percentage, but the drop below the 5% threshold is evident)
- The filing is passive under Rule 13d-1(c), with no intent to influence control
- Shares are held through wholly-owned or majority-owned subsidiaries including Menora Mivtachim Pensions and Gemel Ltd. (4.45%), Menora Mivtachim Insurance Ltd. (0.51%), and others
Financial Impact
Stake reduced from above 5% to 4.99%; no dollar value stated for the reduction
Risk Factors
- The reduction below 5% could signal a gradual exit by a long-term institutional holder
- No stated reason for the reduction; could be portfolio rebalancing rather than a negative view on Teva
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001178913-26-005117 |
| Document: 0001178913-26-005117-index.html | 0001178913-26-005117 |
| Document: 0001178913-26-005117.txt | 0001178913-26-005117 |
Track record
61 reports on TEVA
6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
- Nov 12, 20264d ago 3 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Viewing Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers